| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Radiology, Vol 197, 533-538, Copyright © 1995 by Radiological Society of North America
ARTICLES |
C Zimmer, R Weissleder, K Poss, A Bogdanova, SC Wright Jr and WS Enochs
Department of Radiology, Massachusetts General Hospital, Boston, USA.
PURPOSE: To determine whether phagocytosis can be observed in vivo in glioma cells. MATERIALS AND METHODS: Rat C6 glioma cells were studied in culture and after intracerebral implantation into 13 rats. Monocrystalline iron oxide nanoparticles (MION), a model marker of phagocytosis, was administered intravenously to tumor-bearing rats at 2- 20 mg of iron per kilogram. Magnetic resonance (MR) imaging was performed at multiple time points. RESULTS: Glioma cells in culture showed uptake of MION in amounts of up to 10 ng of iron per 10(6) cells, corresponding to approximately 50,000 particles per cell. Fluorescently labeled MION was found to be located primarily in tubular lysosomes. Intracerebral gliomas showed characteristic changes in signal intensity at MR imaging that peaked 12 hours after administration of MION and lasted up to 5 days; these changes corresponded to uptake and subsequent biodegradation of MION by tumor cells. CONCLUSION: Phagocytosis of glioma cells can be detected in vivo with iron oxide-enhanced MR imaging, and this may permit accurate delineation of tumor margins.
This article has been cited by other articles:
|
|
 |
|
  G. Bierry, F. Jehl, N. Boehm, P. Robert, G. Prevost, J.-L. Dietemann, H. Desal, and S. Kremer Macrophage Activity in Infected Areas of an Experimental Vertebral Osteomyelitis Model: USPIO-enhanced MR Imaging--Feasibility Study Radiology, July 1, 2008; 248(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Morris, A. R. Olzinski, R. E. Bernard, K. Aravindhan, R. C. Mirabile, R. Boyce, R. N. Willette, and B. M. Jucker p38 MAPK Inhibition Reduces Aortic Ultrasmall Superparamagnetic Iron Oxide Uptake in a Mouse Model of Atherosclerosis: MRI Assessment Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 265 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Dousset, B. Brochet, M.S.A. Deloire, L. Lagoarde, B. Barroso, J.-M. Caille, and K.G. Petry MR Imaging of Relapsing Multiple Sclerosis Patients Using Ultra-Small-Particle Iron Oxide and Compared with Gadolinium. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1000 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Taschner, S. G. Wetzel, M. Tolnay, J. Froehlich, A. Merlo, and E. W. Radue Characteristics of Ultrasmall Superparamagnetic Iron Oxides in Patients with Brain Tumors Am. J. Roentgenol., December 1, 2005; 185(6): 1477 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nolte, G. H. Vince, M. Maurer, C. Herbold, R. Goldbrunner, L. Solymosi, G. Stoll, and M. Bendszus Iron Particles Enhance Visualization of Experimental Gliomas with High-Resolution Sonography AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1469 - 1474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Anzai, C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, et al. Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10-enhanced MR Imaging: Phase III Safety and Efficacy Study Radiology, September 1, 2003; 228(3): 777 - 788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Kaim, T. Wischer, T. O'Reilly, G. Jundt, J. Frohlich, G. K. von Schulthess, and P. R. Allegrini MR Imaging with Ultrasmall Superparamagnetic Iron Oxide Particles in Experimental Soft-Tissue Infections in Rats Radiology, December 1, 2002; 225(3): 808 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Varallyay, G. Nesbit, L. L. Muldoon, R. R. Nixon, J. Delashaw, J. I. Cohen, A. Petrillo, D. Rink, and E. A. Neuwelt Comparison of Two Superparamagnetic Viral-Sized Iron Oxide Particles Ferumoxides and Ferumoxtran-10 with a Gadolinium Chelate in Imaging Intracranial Tumors AJNR Am. J. Neuroradiol., April 1, 2002; 23(4): 510 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Knauth, T. Egelhof, S. U. Roth, C. R. Wirtz, and K. Sartor Monocrystalline Iron Oxide Nanoparticles: Possible Solution to the Problem of Surgically Induced Intracranial Contrast Enhancement in Intraoperative MR Imaging AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 99 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Hauger, C. Delalande, C. Deminière, B. Fouqueray, C. Ohayon, S. Garcia, H. Trillaud, C. Combe, and N. Grenier Nephrotoxic Nephritis and Obstructive Nephropathy: Evaluation with MR Imaging Enhanced with Ultrasmall Superparamagnetic Iron Oxide-Preliminary Findings in a Rat Model Radiology, December 1, 2000; 217(3): 819 - 826. [Abstract] [Full Text]
|
|
|
|
|
|
A. Moore, E. Marecos, A. Bogdanov Jr, and R. Weissleder Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model Radiology, February 1, 2000; 214(2): 568 - 574. [Abstract] [Full Text]
|
|
|
|
|
|
M. Knauth, N. Aras, C. R. Wirtz, A. Dörfler, T. Engelhorn, and K. Sartor Surgically Induced Intracranial Contrast Enhancement: Potential Source of Diagnostic Error in Intraoperative MR Imaging AJNR Am. J. Neuroradiol., September 1, 1999; 20(8): 1547 - 1553. [Abstract] [Full Text]
|
|
|
|
|
|
V. Dousset, L. Ballarino, C. Delalande, M. Coussemacq, P. Canioni, K. G. Petry, and J.-M. Caillé Comparison of Ultrasmall Particles of Iron Oxide (USPIO)-Enhanced T2-Weighted, Conventional T2-Weighted, and Gadolinium-Enhanced T1-Weighted MR Images in Rats with Experimental Autoimmune Encephalomyelitis AJNR Am. J. Neuroradiol., February 1, 1999; 20(2): 223 - 227. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
